CLINICAL_TRIALS
withdrawal
· 2011-11-11
Clinical Trial Update: Phase 1 Study of Zoledronic Acid in Sickle Cell Disease [Phase 1, Phase 2]
Summary
A Phase 1/Phase 2 trial evaluating zoledronic acid for sickle cell disease has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Virginia Commonwealth University | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: WITHDRAWN